Early glottic cancer recurrence: A critical review on its current management
LG Locatello, C Bruno, O Gallo - Critical Reviews in Oncology/Hematology, 2021 - Elsevier
Introduction Recurrent early glottic cancer (rEGC) poses several issues in terms of timely
diagnosis, correct re-staging, and treatment. We want to critically review the latest evidence …
diagnosis, correct re-staging, and treatment. We want to critically review the latest evidence …
CD98 expression can be a predictive factor of resistance to radiotherapy in head and neck squamous cell carcinoma
H Suzuki, Y Kawasaki, S Suzuki, T Yamada… - Polish Journal of …, 2023 - termedia.pl
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of cancer
worldwide, affecting more than 6.6 million people annually [1, 2]. The treatment options for …
worldwide, affecting more than 6.6 million people annually [1, 2]. The treatment options for …